|
|
Volumn 42, Issue 2, 1997, Pages 180-
|
|
Coronary artery stenting in MI and Abciximab: a necessary combination?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
ANGIOCARDIOGRAPHY;
HEART INFARCTION;
HUMAN;
INSTRUMENTATION;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NOTE;
RADIOGRAPHY;
RECURRENT DISEASE;
STENT;
SURVIVAL RATE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
RECURRENCE;
STENTS;
SURVIVAL RATE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0031254733
PISSN: 00986569
EISSN: None
Source Type: Journal
DOI: 10.1002/(sici)1097-0304(199710)42:2<180::aid-ccd17>3.0.co;2-s Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
